Allogeneic stem cell therapy uses donor stem cells such as mesenchymal stem cells (MSCs). They have been shown to provide pain relief while improving joint function. Studies indicate that MSCs can differentiate into cartilage, bone, ligament, tendon and release bioactive factors that promote healing and reduce inflammation in various areas throughout the body. These therapies are minimally invasive and can be a viable alternative to traditional treatments like corticosteroids and surgery.
Here are some key points:
- Mesenchymal Stem Cells (MSCs): These cells are injected into the affected joint to promote healing and regeneration of cartilage, ligaments, and tendons while reducing inflammation and improving joint function.
- Minimally Invasive: Unlike traditional surgeries, allogeneic stem cell therapy is less invasive, typically taking less than an hour and requiring little to no recovery time. Requires no blood or bone marrow draw prior to procedure.
- Natural Healing: Stem cells activate the body’s natural repair processes, helping to regenerate damaged tissues and restore joint health.
- Safety and Efficacy: Studies have shown that allogeneic stem cell treatments can significantly improve joint pain and cartilage thickness, making them a promising option for patients with osteoarthritis and other joint conditions.
- Potential for Delaying Surgery: Stem cell therapy may delay or even prevent the need for invasive surgeries, providing long-lasting relief without the risks associated with traditional treatments.